查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2022-2029 年壓力性尿失禁的全球市場
市場調查報告書
商品編碼
1140736

2022-2029 年壓力性尿失禁的全球市場

Global Stress Urinary Incontinence Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 170 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

預計壓力性尿失禁市場在預測期間（2022-2029 年）將以 6.91% 的複合年增長率增長。

壓力性尿失禁 (SUI) 是膀胱和尿道受到突然壓力，導致括約肌短時間張開，導致尿液漏出的現象。在輕度 SUI 中，可能會通過突然的劇烈運動（例如鍛煉、打噴嚏、大笑或咳嗽）施加壓力。壓力性尿失禁更為嚴重，並且可以通過不太有力的運動（例如站立、行走或彎腰）洩漏。泌尿意外只不過是幾滴尿液浸入了你的衣服。 SUI 是女性常見的膀胱問題。在男性中較少見。推動壓力性尿失禁市場增長的主要因素是世界老年人口的增加和世界慢性病患病率的增加。此外，尿失禁患病率的上升是預計將在未來一段時間內為市場帶來顯著增長的主要因素。

市場動態。世界老齡化社會的到來推動市場增長

尿失禁是尿液的意外洩漏。雖然它可能發生在任何人身上，但尿失禁在老年人中更為常見，尤其是老年女性。尿失禁通常可以治愈或控制。隨著人們年齡的增長，他們的膀胱肌肉、盆底肌肉和其他肌肉會變弱，從而產生可能會刺激尿失禁原因的問題。根據世界衛生組織 2021 年發布的報告，到 2030 年，全球六分之一的人將超過 60 歲。屆時，60歲及以上人口將從2020年的10億增加到2050年的14億，世界60歲及以上人口將翻一番，達到21億。這樣，老年人失禁的增加是推動未來市場增長的主要因素。

但是，對失禁的低意識是市場增長的障礙。失禁意識低下可能會抑制壓力性尿失禁市場的銷售增長。此外，與女性尿失禁相關的尿失禁、大便失禁、疼痛、器官穿孔等副作用阻礙了壓力性尿失禁市場的銷售增長。

市場細分。在預測期內，陰道內裝置部分預計將成為市場的主導部分。

根據設備類型，壓力性尿失禁市場分為內部尿道設備、內部陰道設備和外部尿道設備。

內部陰道裝置部分進一步分為常規裝置和定制裝置。壓力性尿失禁在女性中比男性更常見。當女性分娩或男性前列腺手術導致盆底肌肉和尿道括約肌的力量趨於減弱時，就會發生壓力性尿失禁。因此，由於這些因素，陰道內裝置有望在市場上佔據主導地位。

壓力性尿失禁是根據醫院、專科診所和門診手術中心等最終用戶進行細分的。

在最終用戶細分市場中，預計醫院將佔據全球尿失禁設備市場的很大份額，因為在醫院接受治療的許多患者都患有尿失禁。由於該行業的技術進步，預計醫院在未來幾年也將以最高的複合年增長率增長。

地理滲透。在預測期內，北美將成為主要地區。

該研究按地區分析了全球市場的壓力性尿失禁市場，包括北美、歐洲、亞太地區、南美、中東和非洲。

預計北美將在 2021 年主導全球壓力性尿失禁市場。預計美國在預測期內將代表北美的大幅增長。由於發達的醫療基礎設施和公眾對最新醫療發展的高度認識，預計壓力性尿失禁在美國將出現增長潛力。預計拉丁美洲在預測期內的價值也將出現顯著增長。預計慢性病增加等因素將推動該地區的市場增長。

由於該地區老年人口的增加和醫療基礎設施的發展，預計亞太地區壓力性尿失禁市場將在預測期內快速增長。

競爭格局。

由於主要食品品牌的存在，壓力性尿失禁市場是一個競爭激烈的市場。促進全球市場增長的主要壓力性尿失禁參與者是康樂保、波士頓科學公司、C. R. Bard, Inc.、ConvaTec Group Plc、Ethicon, Inc、Caldera Medical Inc、Cook Medical、Covidien plc (Medtronic)、Prosurg、公司和 Cogentix 醫療公司。主要參與者正在為全球壓力性尿失禁市場的增長採用新產品發布或擴張策略。一些主要參與者正在遵循合併和合作戰略來擴展業務。例如，2022 年 1 月，康樂保 A/S 完成了對 Atos Medical 的收購。此次收購將使 Colopl 的有機收益按固定匯率增長約 7%。通過此次收購，該公司增加了一個新的業務部門，即耳鼻喉科和呼吸系統，作為共享 Colopl 基礎設施的獨立戰略部門運營。 2020 年 11 月，丹麥醫療器械製造商 Colopl 斥資 1.45 億美元收購了早期公司 Nine Contents Medical，該公司開創了用於治療膀胱過度活動症的植入式脛神經刺激治療。 Nine Contents Medical 正在開發一種治療膀胱過度活動症的創新療法。購買價格包括預付款和額外的未來裡程碑付款。

COVID-19 的影響將對全球壓力性尿失禁市場產生負面影響。

COVID-19 的爆發對全球壓力性尿失禁市場的增長產生了負面影響。對醫院服務的限制影響了尿失禁患者的專業檢查和手術治療。醫生和醫院工作人員正忙於治療 Covid 患者。尿失禁患者避免去醫院就診併購買設備以避免污染。因此，COVID-19 大流行抑制了 2020 年壓力性尿失禁的市場價值。

全球壓力性尿失禁市場報告包含大約 61 個市場數據表、51 個數字，共 170 頁。

內容

第1章調查方法及範圍

  • 調查方法
  • 調查的目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

  • 按設備類型劃分的市場細分
  • 按材料類型劃分的市場細分
  • 按最終用戶劃分的市場細分
  • 按地區劃分的市場細分

第 4 章全球壓力性尿失禁市場動態

  • 影響市場的因素
    • 驅動程序
      • 世界各地的老年人口都在增加。
      • 尿失禁患病率上升
      • 慢性病增加
    • 限制因素
      • 失禁患者群體缺乏認識
      • 與女性尿失禁裝置相關的副作用，例如尿失禁、大便失禁、疼痛和器官穿孔。
    • 影響分析

第5章行業分析

  • 波特五力分析
  • 供應鏈分析
  • 價值鏈分析
  • PEST 分析
  • 價格分析
  • 監管分析
  • 報銷分析
  • 未滿足的需求
  • 專利趨勢

第 6 章 COVID-19 分析

  • 市場上 COVID-19 的分析
    • COVID-19 之前的市場情景
    • 當前 COVID-19 市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 結論

第 7 章按設備類型

  • 內置尿道裝置
  • 外置尿道器械
  • 陰道內器具

第 8 章按材料分類

  • 矽膠
  • 聚氨酯泡沫

第 9 章，最終用戶

  • 醫院
  • 婦科診所
  • 門診手術中心

第 10 章按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 11 章競爭格局

  • 競爭場景
  • 市場定位/份額分析
  • 併購分析

第 12 章公司簡介

  • 康樂保
    • 公司簡介
    • 產品組合和描述
    • 主要亮點
    • 財務概覽
  • Boston Scientific Corporation
  • CR Bard, Inc.
  • ConvaTec Group Plc
  • Ethicon, Inc.
  • Caldera Medical Inc
  • COOK MEDICAL
  • COVIDIEN PLC（MEDTRONIC）
  • PROSURG, INC.
  • Cogentix Medical Inc.（LIST NOT EXHAUSTIVE）
  • Premium Insights

第14章 DataM

簡介目錄
Product Code: DMPH3132

Market Overview

Stress Urinary Incontinence Market was valued at USD XX million in 2021. It is forecasted to reach USD XX million by 2029, growing at a CAGR of 6.91 % during the forecast period (2022-2029).

Stress Urinary Incontinence (SUI) occurs when urine leaks out with sudden pressure on the bladder and urethra, causing the sphincter muscles to open briefly. With mild SUI, the pressure may come from sudden, forceful activity, such as exercise, sneezing, laughing, or coughing. Stress urinary incontinence is more severe and can leak with less vigorous activities such as standing up, walking, or bending over. Urinary accidents range from a few drops of urine, which is soaked in clothes. SUI is a common bladder problem for women. It happens less frequently in men. The major factors propelling the growth of the stress urinary incontinence market are the rising geriatric population across the globe and the increase in chronic diseases across the globe. Moreover, the Rise in the prevalence of urinary incontinence is the major factor expected to deliver significant growth to the market in the upcoming period.

Market Dynamics: Rising geriatric population worldwide drives market growth

Urinary incontinence means that a person leaks urine by accident. Although it may happen to anyone, urinary incontinence is more common in older people, particularly older women. Incontinence can often be healed or controlled. With the growing age, problems such as weak bladder muscles, pelvic floor muscles and others occur in an older population, hence, stimulating the causes of urinary incontinence. As per the World Health Organization report published in 2021, by 2030, 1 in 6 people in the world will be aged 60years or over. At that timeshare, the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion by 2050, and the world's populations of people aged 60 years and older will double (2.1 billion). Thus, increasing incontinence in the elderly population is the major factor stimulating market growth over the forecast years.

However, a Lack of awareness among the incontinent patient population hampers the market growth. The lack of awareness among the incontinent patient population may reduce revenue growth in the stress urinary incontinence market. In addition, side effects such as urinary and faecal incontinence, pain, and organ perforation associated with female urinary incontinence devices deter revenue growth in the stress urinary incontinence market.

Market Segmentation: The internal vaginal device segment is projected to be the dominant segment in the market during the forecast period.

Based on the device type, the stress urinary incontinence market has been classified into internal urethral devices, internal vaginal devices and external urethral devices.

The internal vaginal devices segment can be further categorized into traditional and custom-made devices. Urinary stress incontinence is significantly more common in women than in men. Stress Urinary Incontinence occurs when pelvic floor muscles or urinary sphincter are likely to lose strength, either due to women's childbirth or men's prostate surgery. Thus, due to such factors, the internal vaginal device is expected to hold a dominant position in the market.

The stress urinary incontinence is segmented based on end-user, which includes hospitals, specialty clinics, and ambulatory surgical centers.

Hospital in the end-user segment is expected to have a significant share of the global market for urinary incontinence devices due to the large patient population treated in hospitals suffering from urinary incontinence. Moreover, Hospitals are also expected to grow with the highest CAGR in the forthcoming period with the rise in technological advancement in the industry.

Geographical Penetration: North America is the dominating region during the forecast period.

Based on geography, the study analyzes the stress urinary incontinence market in the global market, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.

North America will be dominant in the global stress urinary incontinence market in 2021. The U.S. is expected to represent considerable growth in North America during the forecast period. In the U.S., stress urinary incontinence is expected to have potential growth due to its well-developed health care infrastructure and high awareness of the latest medical developments among the people. Moreover, Latin America is expected to represent significant growth in terms of value during the forecast period. Factors such as the rise in chronic diseases are expected to propel regional market growth.

The stress urinary incontinence market for the Asia Pacific is expected to observe rapid growth over the forecast period, backed by the growth of the rise in geriatric population & rising healthcare infrastructure in the region.

Competitive Landscape:

The stress urinary incontinence market is highly competitive, owing to the presence of big food brands. The key Stress Urinary Incontinence players which are contributing to the growth of the global market include Coloplast, Boston Scientific Corporation, C. R. Bard, Inc., ConvaTec Group Plc, Ethicon, Inc., Caldera Medical Inc, Cook Medical, Covidien plc (Medtronic), Prosurg, Inc., and Cogentix Medical Inc, among others. The major players are adopting new product launches and expansion strategies for global growth in the stress urinary incontinence market. Some key players follow merger and collaboration strategies to expand their business. For instance, in January 2022, Coloplast A/S completed the acquisition of Atos Medical. This acquisition helps to grow the organic revenue of Coloplast by around 7 % at a constant exchange rate. With this acquisition, the company added a new business segment, ENT & Respiratory Care which is run as a separate strategic unit operating on shared Coloplast infrastructure in their portfolio. In November 2020, Coloplast, a danish medical device company, acquired Nine Continents Medical, Inc., an early-stage company pioneering an implantable tibial nerve stimulation treatment for overactive bladder, for USD 145 million. Nine Continents Medical, Inc. develops innovative solutions for the overactive bladder. This acquisition price includes an upfront cash payment and an additional contingent future milestone payment.

COVID-19 Impact: Negative impact on the global stress urinary incontinence market.

The outbreak of COVID-19 has negatively impacted the growth of the stress urinary incontinence market globally. Restrictions on hospital services have affected the specialized investigation and surgical management of patients with urinary incontinence. Doctors and hospital staff is busy in treated Covid patients. Patients with urinary incontinence avoid visits to hospitals and buy devices to avoid contamination. Therefore, the COVID-19 pandemic has hampered the market value of the stress urinary incontinence market in 2020.

The global stress urinary incontinence market report would provide an access to approximately 61 market data tables, 51 figures and 170 pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Device type
  • 3.2. Market Snippet by Material Type
  • 3.3. Market Snippet by End user
  • 3.4. Market Snippet by Region

4. Global Stress Urinary Incontinence Market-Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising geriatric population across the globe.
      • 4.1.1.2. Rising prevalence of urinary incontinence
      • 4.1.1.3. Increase in chronic diseases
    • 4.1.2. Restraint
      • 4.1.2.1. lack of awareness among incontinent patient population
      • 4.1.2.2. Side effects such as urinary and fecal incontinence, pain, and organ perforation associated with female urinary incontinence devices.
    • 4.1.3. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Value Chain Analysis
  • 5.4. PEST Analysis
  • 5.5. Pricing Analysis
  • 5.6. Regulatory Analysis
  • 5.7. Reimbursement Analysis
  • 5.8. Unmet Needs
  • 5.9. Patent Trends

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Device type

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device type Segment
  • 7.3. Market Attractiveness Index, By Device type Segment
    • 7.3.1. Internal urethral devices
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 7.3.2. External urethral devices
    • 7.3.3. Internal vaginal devices

8. By Material Type

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type Segment
  • 8.3. Market Attractiveness Index, By Material Types channel Segment
    • 8.3.1. Silicone
      • 8.3.1.1. Introduction
      • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 8.3.2. Polyurethane Foam

9. By End-user

  • 9.1. Introduction
  • 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user Segment
  • 9.3. Market Attractiveness Index, By End user channel Segment
    • 9.3.1. Hospitals
      • 9.3.1.1. Introduction
      • 9.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 9.3.2. Gynecology clinics
    • 9.3.3. Ambulatory surgical centers

10. By Region

  • 10.1. Introduction
  • 10.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 10.3. Market Attractiveness Index, By Region
  • 10.4. North America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. U.S.
      • 10.4.6.2. Canada
      • 10.4.6.3. Mexico
  • 10.5. Europe
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. Germany
      • 10.5.6.2. U.K.
      • 10.5.6.3. France
      • 10.5.6.4. Italy
      • 10.5.6.5. Spain
      • 10.5.6.6. Rest of Europe
  • 10.6. South America
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.6.6.1. Brazil
      • 10.6.6.2. Argentina
      • 10.6.6.3. Rest of South America
  • 10.7. Asia Pacific
    • 10.7.1. Introduction
    • 10.7.2. Key Region-Specific Dynamics
    • 10.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device type
    • 10.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
    • 10.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.7.6.1. China
      • 10.7.6.2. India
      • 10.7.6.3. Japan
      • 10.7.6.4. Australia
      • 10.7.6.5. Rest of Asia Pacific
  • 10.8. Middle East and Africa
    • 10.8.1. Introduction
    • 10.8.2. Key Region-Specific Dynamics
    • 10.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device type
    • 10.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
    • 10.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.8.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Coloplast*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Boston Scientific Corporation
  • 12.3. C. R. Bard, Inc.
  • 12.4. ConvaTec Group Plc
  • 12.5. Ethicon, Inc.
  • 12.6. Caldera Medical Inc
  • 12.7. COOK MEDICAL
  • 12.8. COVIDIEN PLC (MEDTRONIC)
  • 12.9. PROSURG, INC.
  • 12.10. Cogentix Medical Inc. (LIST NOT EXHAUSTIVE)
  • 12.13. Premium Insights

14. DataM Intelligence Analysis

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us